[1]Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an irondependent form of nonapoptotic cell death\[J\]. Cell, 2012, 149(5): 1060-1072.
[2]Dixon SJ, Patel DN, Welsch M, et al. Pharmacological inhibition of cystineglutamate exchange induces endoplasmic reticulum stress and ferroptosis\[J\]. Elife, 2014, 3: e02523.
[3]Hirschhorn T, Stockwell BR. The development of the concept of ferroptosis\[J\]. Free Radic Biol Med, 2019, 133: 130-143.
[4]Hernandez EP, Kusakisako K, Talactac MR, et al. Induction of intracellular ferritin expression in embryoderived Ixodes scapularis cell line (ISE6)\[J\]. Sci Rep, 2018, 8(1): 16566.
[5]Jia F, Song N, Wang W, et al. High dietary iron supplement induces the nigrostriatal dopaminergic neurons lesion in transgenic mice expressing mutant A53T human alphasynuclein\[J\]. Front Aging Neurosci, 2018, 10: 97.
[6]Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation\[J\]. Trends Cell Biol, 2016, 26(3): 165-176.
[7]Hou W, Xie Y, Song X, et al. Autophagy promotes ferroptosis by degradation of ferritin\[J\]. Autophagy, 2016, 12(8): 1425-1428.
[8]SantanaCodina N, Mancias JD. The role of NCOA4mediated ferritinophagy in health and disease\[J\]. Pharmaceuticals (Basel), 2018, 11(4): 114.
[9]Quiles Del Rey M, Mancias JD. NCOA4mediated ferritinophagy: a potential link to neurodegeneration\[J\]. Front Neurosci, 2019, 13: 238.
[10]Sun X, Ou Z, Xie M, et al. HSPB1 as a novel regulator of ferroptotic cancer cell death\[J\]. Oncogene, 2015, 34(45): 5617-5625.
[11]Sun X, Ou Z, Chen R, et al. Activation of the p62Keap1NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells\[J\]. Hepatology, 2016, 63(1): 173-184.
[12]Kagan VE, Mao G, Qu F, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis\[J\]. Nat Chem Biol, 2017, 13(1): 81-90.
[13]Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition\[J\]. Nat Chem Biol, 2017, 13(1): 91-98.
[14]Yuan H, Li X, Zhang X, et al. Identification of ACSL4 as a biomarker and contributor of ferroptosis\[J\]. Biochem Biophys Res Commun, 2016, 478(3): 1338-1343.
[15]Gaschler MM, Stockwell BR. Lipid peroxidation in cell death\[J\]. Biochem Biophys Res Commun, 2017, 482(3): 419-425.
[16]Fenton HJH. Oxidation of tartaric acid in presence of iron\[J\]. J Chem Soc Trans, 1894, 65: 899-910.
[17]Kuhn H, Banthiya S, van Leyen K. Mammalian lipoxygenases and their biological relevance\[J\]. Biochim Biophys Acta, 2015, 1851(4): 308-330.
[18]Reis A, Spickett CM. Chemistry of phospholipid oxidation\[J\]. Biochim Biophys Acta, 2012, 1818(10): 2374-2387.
[19]Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress\[J\]. Curr Med Chem, 2005, 12(10): 1161-1208.
[20]Yang WS, Kim KJ, Gaschler MM, et al. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis\[J\]. Proc Natl Acad Sci U S A, 2016, 113(34): E4966-4975.
[21]Zhong H, Yin H. Role of lipid peroxidation derived 4hydroxynonenal (4HNE) in cancer: focusing on mitochondria\[J\]. Redox Biol, 2015, 4: 193-199.
[22]Shimada K, Skouta R, Kaplan A, et al. Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis\[J\]. Nat Chem Biol, 2016, 12(7): 497-503.
[23]Moosmann B, Behl C. Selenoproteins, cholesterollowering drugs, and the consequences: revisiting of the mevalonate pathway\[J\]. Trends Cardiovasc Med, 2004, 14(7): 273-281.
[24]Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4\[J\]. Cell, 2014, 156(1-2): 317-331.
[25]Bersuker K, Hendricks JM, Li Z, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis\[J\]. Nature, 2019, 575(7784): 688-692.
[26]Angeli JPF, Shah R, Pratt DA, et al. Ferroptosis inhibition: mechanisms and opportunities\[J\]. Trends Pharmacol Sci, 2017, 38(5): 489-498.
[27]Koppula P, Zhang Y, Zhuang L, et al. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer\[J\]. Cancer Commun (Lond), 2018, 38(1): 12.
[28]Hayano M, Yang WS, Corn CK, et al. Loss of cysteinyltRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation\[J\]. Cell Death Differ, 2016, 23(2): 270-278.
[29]Gao M, Monian P, Quadri N, et al. Glutaminolysis and transferrin regulate ferroptosis\[J\]. Mol Cell, 2015, 59(2): 298-308.
[30]Pandur E, Pap R, Varga E, et al. Relationship of iron metabolism and shortterm cuprizone treatment of C57BL/6 mice\[J\]. Int J Mol Sci, 2019, 20(9).pii:E2257.
[31]Massie A, Schallier A, Kim SW, et al. Dopaminergic neurons of system xc-deficient mice are highly protected against 6hydroxydopamineinduced toxicity\[J\]. FASEB J, 2011, 25(4): 1359-1369.
[32]Torii S, Shintoku R, Kubota C, et sl. An essential role for functional lyosomes in ferroptosis of cancer cells\[J\]. Biochem J, 2016, 473(6): 769-777.
[33]Das M. Combined treatment for locally advanced pancreatic cancer\[J\]. Lancet Oncol, 2019, 20(7): e351.
[34]Perusina Lanfranca M, Thompson JK, Bednar F, et al. Metabolism and epigenetics of pancreatic cancer stem cells\[J\]. Semin Cancer Biol, 2019, 57: 19-26.
[35]Zhu S, Zhang Q, Sun X, et al. HSPA5 regulates ferroptotic cell death in cancer cells\[J\]. Cancer Res,2017, 77(8): 2064-2077.
[36]Tyagi RK, Gleeson PJ, Arnold L, et al. Highlevel artemisininresistance with quinine coresistance emerges in P. falciparum malaria under in vivo artesunate pressure\[J\]. BMC Med, 2018, 16(1): 181.
[37]Eling N, Reuter L, Hazin J, et al. Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells\[J\]. Oncoscience, 2015, 2(5): 517-532.
[38]Vandewynckel YP, Laukens D, Geerts A, et al. Therapeutic effects of artesunate in hepatocellular carcinoma: repurposing an ancient antimalarial agent\[J\]. Eur J Gastroenterol Hepatol, 2014, 26(8): 861-870.
[39]Ou W, Mulik RS, Anwar A, et al. Lowdensity lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma\[J\]. Free Radic Biol Med, 2017, 112: 597-607.
[40]Bai T, Wang S, Zhao Y, et al. Haloperidol, a sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells\[J\]. Biochem Biophys Res Commun, 2017, 491(4): 919-925.
[41]Abdalkader M, Lampinen R, Kanninen KM, et al. Targeting Nrf2 to suppress ferroptosis and mitochondrial dysfunction in neurodegeneration\[J\]. Front Neurosci, 2018, 12: 466.
[42]Wang Z, Ding Y, Wang X, et al. Pseudolaric acid B triggers ferroptosis in glioma cells via activation of Nox4 and inhibition of xCT[J]. Cancer Lett, 2018, 428: 21-33.
[43]Brown JA, Ferrando A. Glucocorticoid resistance in acute lymphoblastic leukemia: BIM finally\[J\]. Cancer Cell, 2018, 34(6): 869-871.
[44]Karuppagounder SS, Alin L, Chen Y, et al. Nacetylcysteine targets 5 lipoxygenasederived, toxic lipids and can synergize with prostaglandin E2 to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice\[J\]. Ann Neurol, 2018, 84(6): 854-872.
[45]Sato H, Shiiya A, Kimata M, et al. Redox imbalance in cystine/glutamate transporterdeficient mice\[J\]. J Biol Chem, 2005, 280(45): 37423-37429.
|